Circulating microRNA-1a is a biomarker of Graves’ disease patients with atrial fibrillation

go back to reference M. den Hoed, M. Eijgelsheim, T. Esko, B.J. Brundel, D.S. Peal, D.M. Evans, I.M. Nolte, A.V. Segre, H. Holm, R.E. Handsaker, H.J. Westra, T. Johnson, A. Isaacs, J. Yang, A. Lundby, J.H. Zhao, Y.J. Kim, M.J. Go, P. Almgren, M. Bochud, G. Boucher, M.C. Cornelis, D. Gudbjartsson, D. Hadley, P. van der Harst, C. Hayward, M. den Heijer, W. Igl, A.U. Jackson, Z. Kutalik, J. Luan, J.P. Kemp, K. Kristiansson, C. Ladenvall, M. Lorentzon, M.E. Montasser, O.T. Njajou, P.F. O’Reilly, S. Padmanabhan, B. St Pourcain, T. Rankinen, P. Salo, T. Tanaka, N.J. Timpson, V. Vitart, L. Waite, W. Wheeler, W. Zhang, H.H. Draisma, M.F. Feitosa, K.F. Kerr, P.A. Lind, E. Mihailov, N.C. Onland-Moret, C. Song, M.N. Weedon, W. Xie, L. Yengo, D. Absher, C.M. Albert, A. Alonso, D.E. Arking, P.I. de Bakker, B. Balkau, C. Barlassina, P. Benaglio, J.C. Bis, N. Bouatia-Naji, S. Brage, S.J. Chanock, P.S. Chines, M. Chung, D. Darbar, C. Dina, M. Dorr, P. Elliott, S.B. Felix, K. Fischer, C. Fuchsberger, E.J. de Geus, P. Goyette, V. Gudnason, T.B. Harris, A.L. Hartikainen, A.S. Havulinna, S.R. Heckbert, A.A. Hicks, A. Hofman, S. Holewijn, F. Hoogstra-Berends, J.J. Hottenga, M.K. Jensen, A. Johansson, J. Junttila, S. Kaab, B. Kanon, S. Ketkar, K.T. Khaw, J.W. Knowles, A.S. Kooner, J.A. Kors, M. Kumari, L. Milani, P. Laiho, E.G. Lakatta, C. Langenberg, M. Leusink, Y. Liu, R.N. Luben, K.L. Lunetta, S.N. Lynch, M.R. Markus, P. Marques-Vidal, I. Mateo Leach, W.L. McArdle, S.A. McCarroll, S.E. Medland, K.A. Miller, G.W. Montgomery, A.C. Morrison, M. Muller-Nurasyid, P. Navarro, M. Nelis, J.R. O’Connell, C.J. O’Donnell, K.K. Ong, A.B. Newman, A. Peters, O. Polasek, A. Pouta, P.P. Pramstaller, B.M. Psaty, D.C. Rao, S.M. Ring, E.J. Rossin, D. Rudan, S. Sanna, R.A. Scott, J.S. Sehmi, S. Sharp, J.T. Shin, A.B. Singleton, A.V. Smith, N. Soranzo, T.D. Spector, C. Stewart, H.M. Stringham, K.V. Tarasov, A.G. Uitterlinden, L. Vandenput, S.J. Hwang, J.B. Whitfield, C. Wijmenga, S.H. Wild, G. Willemsen, J.F. Wilson, J.C. Witteman, A. Wong, Q. Wong, Y. Jamshidi, P. Zitting, J.M. Boer, D.I. Boomsma, I.B. Borecki, C.M. van Duijn, U. Ekelund, N.G. Forouhi, P. Froguel, A. Hingorani, E. Ingelsson, M. Kivimaki, R.A. Kronmal, D. Kuh, L. Lind, N.G. Martin, B.A. Oostra, N.L. Pedersen, T. Quertermous, J.I. Rotter, Y.T. van der Schouw, W.M. Verschuren, M. Walker, D. Albanes, D.O. Arnar, T.L. Assimes, S. Bandinelli, M. Boehnke, R.A. de Boer, C. Bouchard, W.L. Caulfield, J.C. Chambers, G. Curhan, D. Cusi, J. Eriksson, L. Ferrucci, W.H. van Gilst, N. Glorioso, J. de Graaf, L. Groop, U. Gyllensten, W.C. Hsueh, F.B. Hu, H.V. Huikuri, D.J. Hunter, C. Iribarren, B. Isomaa, M.R. Jarvelin, A. Jula, M. Kahonen, L.A. Kiemeney, M.M. van der Klauw, J.S. Kooner, P. Kraft, L. Iacoviello, T. Lehtimaki, M.L. Lokki, B.D. Mitchell, G. Navis, M.S. Nieminen, C. Ohlsson, N.R. Poulter, L. Qi, O.T. Raitakari, E.B. Rimm, J.D. Rioux, F. Rizzi, I. Rudan, V. Salomaa, P.S. Sever, D.C. Shields, A.R. Shuldiner, J. Sinisalo, A.V. Stanton, R.P. Stolk, D.P. Strachan, J.C. Tardif, U. Thorsteinsdottir, J. Tuomilehto, D.J. van Veldhuisen, J. Virtamo, J. Viikari, P. Vollenweider, G. Waeber, E. Widen, Y.S. Cho, J.V. Olsen, P.M. Visscher, C. Willer, L. Franke, B.C. Global, C.A. Consortium, J. Erdmann, J.R. Thompson, P.G. Consortium, A. Pfeufer, Q.G. Consortium, N. Sotoodehnia, Q.-I. Consortium, C. Newton-Cheh, C.-A. Consortium, P.T. Ellinor, B.H. Stricker, A. Metspalu, M. Perola, J.S. Beckmann, G.D. Smith, K. Stefansson, N.J. Wareham, P.B. Munroe, O.C. Sibon, D.J. Milan, H. Snieder, N.J. Samani, R.J. Loos, Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat. Genet. 45(6), 621–631 (2013)CrossRef M. den Hoed, M. Eijgelsheim, T. Esko, B.J. Brundel, D.S. Peal, D.M. Evans, I.M. Nolte, A.V. Segre, H. Holm, R.E. Handsaker, H.J. Westra, T. Johnson, A. Isaacs, J. Yang, A. Lundby, J.H. Zhao, Y.J. Kim, M.J. Go, P. Almgren, M. Bochud, G. Boucher, M.C. Cornelis, D. Gudbjartsson, D. Hadley, P. van der Harst, C. Hayward, M. den Heijer, W. Igl, A.U. Jackson, Z. Kutalik, J. Luan, J.P. Kemp, K. Kristiansson, C. Ladenvall, M. Lorentzon, M.E. Montasser, O.T. Njajou, P.F. O’Reilly, S. Padmanabhan, B. St Pourcain, T. Rankinen, P. Salo, T. Tanaka, N.J. Timpson, V. Vitart, L. Waite, W. Wheeler, W. Zhang, H.H. Draisma, M.F. Feitosa, K.F. Kerr, P.A. Lind, E. Mihailov, N.C. Onland-Moret, C. Song, M.N. Weedon, W. Xie, L. Yengo, D. Absher, C.M. Albert, A. Alonso, D.E. Arking, P.I. de Bakker, B. Balkau, C. Barlassina, P. Benaglio, J.C. Bis, N. Bouatia-Naji, S. Brage, S.J. Chanock, P.S. Chines, M. Chung, D. Darbar, C. Dina, M. Dorr, P. Elliott, S.B. Felix, K. Fischer, C. Fuchsberger, E.J. de Geus, P. Goyette, V. Gudnason, T.B. Harris, A.L. Hartikainen, A.S. Havulinna, S.R. Heckbert, A.A. Hicks, A. Hofman, S. Holewijn, F. Hoogstra-Berends, J.J. Hottenga, M.K. Jensen, A. Johansson, J. Junttila, S. Kaab, B. Kanon, S. Ketkar, K.T. Khaw, J.W. Knowles, A.S. Kooner, J.A. Kors, M. Kumari, L. Milani, P. Laiho, E.G. Lakatta, C. Langenberg, M. Leusink, Y. Liu, R.N. Luben, K.L. Lunetta, S.N. Lynch, M.R. Markus, P. Marques-Vidal, I. Mateo Leach, W.L. McArdle, S.A. McCarroll, S.E. Medland, K.A. Miller, G.W. Montgomery, A.C. Morrison, M. Muller-Nurasyid, P. Navarro, M. Nelis, J.R. O’Connell, C.J. O’Donnell, K.K. Ong, A.B. Newman, A. Peters, O. Polasek, A. Pouta, P.P. Pramstaller, B.M. Psaty, D.C. Rao, S.M. Ring, E.J. Rossin, D. Rudan, S. Sanna, R.A. Scott, J.S. Sehmi, S. Sharp, J.T. Shin, A.B. Singleton, A.V. Smith, N. Soranzo, T.D. Spector, C. Stewart, H.M. Stringham, K.V. Tarasov, A.G. Uitterlinden, L. Vandenput, S.J. Hwang, J.B. Whitfield, C. Wijmenga, S.H. Wild, G. Willemsen, J.F. Wilson, J.C. Witteman, A. Wong, Q. Wong, Y. Jamshidi, P. Zitting, J.M. Boer, D.I. Boomsma, I.B. Borecki, C.M. van Duijn, U. Ekelund, N.G. Forouhi, P. Froguel, A. Hingorani, E. Ingelsson, M. Kivimaki, R.A. Kronmal, D. Kuh, L. Lind, N.G. Martin, B.A. Oostra, N.L. Pedersen, T. Quertermous, J.I. Rotter, Y.T. van der Schouw, W.M. Verschuren, M. Walker, D. Albanes, D.O. Arnar, T.L. Assimes, S. Bandinelli, M. Boehnke, R.A. de Boer, C. Bouchard, W.L. Caulfield, J.C. Chambers, G. Curhan, D. Cusi, J. Eriksson, L. Ferrucci, W.H. van Gilst, N. Glorioso, J. de Graaf, L. Groop, U. Gyllensten, W.C. Hsueh, F.B. Hu, H.V. Huikuri, D.J. Hunter, C. Iribarren, B. Isomaa, M.R. Jarvelin, A. Jula, M. Kahonen, L.A. Kiemeney, M.M. van der Klauw, J.S. Kooner, P. Kraft, L. Iacoviello, T. Lehtimaki, M.L. Lokki, B.D. Mitchell, G. Navis, M.S. Nieminen, C. Ohlsson, N.R. Poulter, L. Qi, O.T. Raitakari, E.B. Rimm, J.D. Rioux, F. Rizzi, I. Rudan, V. Salomaa, P.S. Sever, D.C. Shields, A.R. Shuldiner, J. Sinisalo, A.V. Stanton, R.P. Stolk, D.P. Strachan, J.C. Tardif, U. Thorsteinsdottir, J. Tuomilehto, D.J. van Veldhuisen, J. Virtamo, J. Viikari, P. Vollenweider, G. Waeber, E. Widen, Y.S. Cho, J.V. Olsen, P.M. Visscher, C. Willer, L. Franke, B.C. Global, C.A. Consortium, J. Erdmann, J.R. Thompson, P.G. Consortium, A. Pfeufer, Q.G. Consortium, N. Sotoodehnia, Q.-I. Consortium, C. Newton-Cheh, C.-A. Consortium, P.T. Ellinor, B.H. Stricker, A. Metspalu, M. Perola, J.S. Beckmann, G.D. Smith, K. Stefansson, N.J. Wareham, P.B. Munroe, O.C. Sibon, D.J. Milan, H. Snieder, N.J. Samani, R.J. Loos, Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat. Genet. 45(6), 621–631 (2013)CrossRef

go back to reference C.T. Sawin, A. Geller, P.A. Wolf, A.J. Belanger, E. Baker, P. Bacharach, P.W. Wilson, E.J. Benjamin, R.B. D’Agostino, Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N. Engl. J. Med. 331(19), 1249–1252 (1994)CrossRefPubMed C.T. Sawin, A. Geller, P.A. Wolf, A.J. Belanger, E. Baker, P. Bacharach, P.W. Wilson, E.J. Benjamin, R.B. D’Agostino, Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N. Engl. J. Med. 331(19), 1249–1252 (1994)CrossRefPubMed

go back to reference J. Heeringa, E.H. Hoogendoorn, W.M. van der Deure, A. Hofman, R.P. Peeters, W.C. Hop, M. den Heijer, T.J. Visser, J.C. Witteman, High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch. Intern. Med. 168(20), 2219–2224 (2008)CrossRefPubMed J. Heeringa, E.H. Hoogendoorn, W.M. van der Deure, A. Hofman, R.P. Peeters, W.C. Hop, M. den Heijer, T.J. Visser, J.C. Witteman, High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch. Intern. Med. 168(20), 2219–2224 (2008)CrossRefPubMed

go back to reference M.D. Gammage, J.V. Parle, R.L. Holder, L.M. Roberts, F.D. Hobbs, S. Wilson, M.C. Sheppard, J.A. Franklyn, Association between serum free thyroxine concentration and atrial fibrillation. Arch. Intern. Med. 167(9), 928–934 (2007)CrossRefPubMed M.D. Gammage, J.V. Parle, R.L. Holder, L.M. Roberts, F.D. Hobbs, S. Wilson, M.C. Sheppard, J.A. Franklyn, Association between serum free thyroxine concentration and atrial fibrillation. Arch. Intern. Med. 167(9), 928–934 (2007)CrossRefPubMed

go back to reference X. Luo, B. Yang, S. Nattel, MicroRNAs and atrial fibrillation: mechanisms and translational potential. Nat. Rev. Cardiol. 12(2), 80–90 (2015)CrossRefPubMed X. Luo, B. Yang, S. Nattel, MicroRNAs and atrial fibrillation: mechanisms and translational potential. Nat. Rev. Cardiol. 12(2), 80–90 (2015)CrossRefPubMed

go back to reference G. Santulli, G. Iaccarino, N. De Luca, B. Trimarco, G. Condorelli, Atrial fibrillation and microRNAs. Front. Physiol. 5, 15 (2014)PubMedCentralCrossRefPubMed G. Santulli, G. Iaccarino, N. De Luca, B. Trimarco, G. Condorelli, Atrial fibrillation and microRNAs. Front. Physiol. 5, 15 (2014)PubMedCentralCrossRefPubMed

go back to reference R. Liu, X. Ma, L. Xu, D. Wang, X. Jiang, W. Zhu, B. Cui, G. Ning, D. Lin, S. Wang, Differential microRNA expression in peripheral blood mononuclear cells from Graves’ disease patients. J. Clin. Endocrinol. Metab. 97(6), E968–E972 (2012)CrossRefPubMed R. Liu, X. Ma, L. Xu, D. Wang, X. Jiang, W. Zhu, B. Cui, G. Ning, D. Lin, S. Wang, Differential microRNA expression in peripheral blood mononuclear cells from Graves’ disease patients. J. Clin. Endocrinol. Metab. 97(6), E968–E972 (2012)CrossRefPubMed

go back to reference R.M. O’Connell, D.S. Rao, A.A. Chaudhuri, D. Baltimore, Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10(2), 111–122 (2010)CrossRefPubMed R.M. O’Connell, D.S. Rao, A.A. Chaudhuri, D. Baltimore, Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10(2), 111–122 (2010)CrossRefPubMed

go back to reference M. Hulsmans, P. Sinnaeve, B. Van der Schueren, C. Mathieu, S. Janssens, P. Holvoet, Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease. J. Clin. Endocrinol. Metab. 97(7), E1213–E1218 (2012)CrossRefPubMed M. Hulsmans, P. Sinnaeve, B. Van der Schueren, C. Mathieu, S. Janssens, P. Holvoet, Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease. J. Clin. Endocrinol. Metab. 97(7), E1213–E1218 (2012)CrossRefPubMed

go back to reference D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281–297 (2004)PubMed D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281–297 (2004)PubMed

go back to reference S. Fichtlscherer, S. De Rosa, H. Fox, T. Schwietz, A. Fischer, C. Liebetrau, M. Weber, C.W. Hamm, T. Roxe, M. Muller-Ardogan, A. Bonauer, A.M. Zeiher, S. Dimmeler, Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107(5), 677–684 (2010)CrossRefPubMed S. Fichtlscherer, S. De Rosa, H. Fox, T. Schwietz, A. Fischer, C. Liebetrau, M. Weber, C.W. Hamm, T. Roxe, M. Muller-Ardogan, A. Bonauer, A.M. Zeiher, S. Dimmeler, Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107(5), 677–684 (2010)CrossRefPubMed

go back to reference M. Karakas, C. Schulte, S. Appelbaum, F. Ojeda, K.J. Lackner, T. Munzel, R.B. Schnabel, S. Blankenberg, T. Zeller Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study. Eur. Heart. J. 38(7), 516–523 (2017) M. Karakas, C. Schulte, S. Appelbaum, F. Ojeda, K.J. Lackner, T. Munzel, R.B. Schnabel, S. Blankenberg, T. Zeller Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study. Eur. Heart. J. 38(7), 516–523 (2017)

go back to reference M.A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A.K. Sood, G.A. Calin, MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 8(8), 467–477 (2011)PubMedCentralCrossRefPubMed M.A. Cortez, C. Bueso-Ramos, J. Ferdin, G. Lopez-Berestein, A.K. Sood, G.A. Calin, MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 8(8), 467–477 (2011)PubMedCentralCrossRefPubMed

go back to reference P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O’Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin, M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105(30), 10513–10518 (2008)PubMedCentralCrossRefPubMed P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O’Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin, M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105(30), 10513–10518 (2008)PubMedCentralCrossRefPubMed

go back to reference Y. Zhao, J.F. Ransom, A. Li, V. Vedantham, M. von Drehle, A.N. Muth, T. Tsuchihashi, M.T. McManus, R.J. Schwartz, D. Srivastava, Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129(2), 303–317 (2007)CrossRefPubMed Y. Zhao, J.F. Ransom, A. Li, V. Vedantham, M. von Drehle, A.N. Muth, T. Tsuchihashi, M.T. McManus, R.J. Schwartz, D. Srivastava, Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129(2), 303–317 (2007)CrossRefPubMed

go back to reference O. Adam, B. Lohfelm, T. Thum, S.K. Gupta, S.L. Puhl, H.J. Schafers, M. Bohm, U. Laufs, Role of miR-21 in the pathogenesis of atrial fibrosis. Basic. Res. Cardiol. 107(5), 278 (2012)CrossRefPubMed O. Adam, B. Lohfelm, T. Thum, S.K. Gupta, S.L. Puhl, H.J. Schafers, M. Bohm, U. Laufs, Role of miR-21 in the pathogenesis of atrial fibrosis. Basic. Res. Cardiol. 107(5), 278 (2012)CrossRefPubMed

go back to reference Z. Girmatsion, P. Biliczki, A. Bonauer, G. Wimmer-Greinecker, M. Scherer, A. Moritz, A. Bukowska, A. Goette, S. Nattel, S.H. Hohnloser, J.R. Ehrlich, Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart. Rhythm. 6(12), 1802–1809 (2009)CrossRefPubMed Z. Girmatsion, P. Biliczki, A. Bonauer, G. Wimmer-Greinecker, M. Scherer, A. Moritz, A. Bukowska, A. Goette, S. Nattel, S.H. Hohnloser, J.R. Ehrlich, Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart. Rhythm. 6(12), 1802–1809 (2009)CrossRefPubMed

go back to reference X. Luo, Z. Pan, H. Shan, J. Xiao, X. Sun, N. Wang, H. Lin, L. Xiao, A. Maguy, X.Y. Qi, Y. Li, X. Gao, D. Dong, Y. Zhang, Y. Bai, J. Ai, L. Sun, H. Lu, X.Y. Luo, Z. Wang, Y. Lu, B. Yang, S. Nattel, MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J. Clin. Invest. 123(5), 1939–1951 (2013)PubMedCentralCrossRefPubMed X. Luo, Z. Pan, H. Shan, J. Xiao, X. Sun, N. Wang, H. Lin, L. Xiao, A. Maguy, X.Y. Qi, Y. Li, X. Gao, D. Dong, Y. Zhang, Y. Bai, J. Ai, L. Sun, H. Lu, X.Y. Luo, Z. Wang, Y. Lu, B. Yang, S. Nattel, MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J. Clin. Invest. 123(5), 1939–1951 (2013)PubMedCentralCrossRefPubMed

go back to reference K. Dawson, R. Wakili, B. Ordog, S. Clauss, Y. Chen, Y. Iwasaki, N. Voigt, X.Y. Qi, M.F. Sinner, D. Dobrev, S. Kaab, S. Nattel, MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation. 127(14), 1466–1475 (2013). 1475e1461-1428CrossRefPubMed K. Dawson, R. Wakili, B. Ordog, S. Clauss, Y. Chen, Y. Iwasaki, N. Voigt, X.Y. Qi, M.F. Sinner, D. Dobrev, S. Kaab, S. Nattel, MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation. 127(14), 1466–1475 (2013). 1475e1461-1428CrossRefPubMed

go back to reference R.F. Duisters, A.J. Tijsen, B. Schroen, J.J. Leenders, V. Lentink, I. van der Made, V. Herias, R.E. van Leeuwen, M.W. Schellings, P. Barenbrug, J.G. Maessen, S. Heymans, Y.M. Pinto, E.E. Creemers, miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res. 104(2), 170–178 (2009). 176p following 178CrossRefPubMed R.F. Duisters, A.J. Tijsen, B. Schroen, J.J. Leenders, V. Lentink, I. van der Made, V. Herias, R.E. van Leeuwen, M.W. Schellings, P. Barenbrug, J.G. Maessen, S. Heymans, Y.M. Pinto, E.E. Creemers, miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res. 104(2), 170–178 (2009). 176p following 178CrossRefPubMed

go back to reference N. Cooley, M.J. Cowley, R.C. Lin, S. Marasco, C. Wong, D.M. Kaye, A.M. Dart, E.A. Woodcock, Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol. Genomics. 44(3), 211–219 (2012)CrossRefPubMed N. Cooley, M.J. Cowley, R.C. Lin, S. Marasco, C. Wong, D.M. Kaye, A.M. Dart, E.A. Woodcock, Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol. Genomics. 44(3), 211–219 (2012)CrossRefPubMed

go back to reference Y. Lu, Y. Zhang, N. Wang, Z. Pan, X. Gao, F. Zhang, Y. Zhang, H. Shan, X. Luo, Y. Bai, L. Sun, W. Song, C. Xu, Z. Wang, B. Yang, MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation. 122(23), 2378–2387 (2010)CrossRefPubMed Y. Lu, Y. Zhang, N. Wang, Z. Pan, X. Gao, F. Zhang, Y. Zhang, H. Shan, X. Luo, Y. Bai, L. Sun, W. Song, C. Xu, Z. Wang, B. Yang, MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation. 122(23), 2378–2387 (2010)CrossRefPubMed

go back to reference T.Y. Ling, X.L. Wang, Q. Chai, T.W. Lau, C.M. Koestler, S.J. Park, R.C. Daly, K.L. Greason, J. Jen, L.Q. Wu, W.F. Shen, W.K. Shen, Y.M. Cha, H.C. Lee, Regulation of the SK3 channel by microRNA-499--potential role in atrial fibrillation. Heart. Rhythm. 10(7), 1001–1009 (2013)PubMedCentralCrossRefPubMed T.Y. Ling, X.L. Wang, Q. Chai, T.W. Lau, C.M. Koestler, S.J. Park, R.C. Daly, K.L. Greason, J. Jen, L.Q. Wu, W.F. Shen, W.K. Shen, Y.M. Cha, H.C. Lee, Regulation of the SK3 channel by microRNA-499--potential role in atrial fibrillation. Heart. Rhythm. 10(7), 1001–1009 (2013)PubMedCentralCrossRefPubMed

go back to reference C. Bernecker, L. Lenz, M.S. Ostapczuk, S. Schinner, H. Willenberg, M. Ehlers, S. Vordenbaumen, J. Feldkamp, M. Schott, MicroRNAs miR-146a1, miR-155_2, and miR-200a1 are regulated in autoimmune thyroid diseases. Thyroid. 22(12), 1294–1295 (2012)CrossRefPubMed C. Bernecker, L. Lenz, M.S. Ostapczuk, S. Schinner, H. Willenberg, M. Ehlers, S. Vordenbaumen, J. Feldkamp, M. Schott, MicroRNAs miR-146a1, miR-155_2, and miR-200a1 are regulated in autoimmune thyroid diseases. Thyroid. 22(12), 1294–1295 (2012)CrossRefPubMed

go back to reference European Heart Rhythm, A., European Association for Cardio-Thoracic, S., A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, I.C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S.H. Hohloser, P. Kolh, J.Y. Le Heuzey, P. Ponikowski, F.H. Rutten, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur. Heart. J. 31(19), 2369–2429 (2010)CrossRef European Heart Rhythm, A., European Association for Cardio-Thoracic, S., A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, I.C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S.H. Hohloser, P. Kolh, J.Y. Le Heuzey, P. Ponikowski, F.H. Rutten, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur. Heart. J. 31(19), 2369–2429 (2010)CrossRef

go back to reference N. Hakimzadeh, A.Y. Nossent, A.M. van der Laan, S.H. Schirmer, M.W. de Ronde, S.J. Pinto-Sietsma, N. van Royen, P.H. Quax, I.E. Hoefer, J.J. Piek, Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery Function. PLoS ONE 10(9), e0137035 (2015)PubMedCentralCrossRefPubMed N. Hakimzadeh, A.Y. Nossent, A.M. van der Laan, S.H. Schirmer, M.W. de Ronde, S.J. Pinto-Sietsma, N. van Royen, P.H. Quax, I.E. Hoefer, J.J. Piek, Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery Function. PLoS ONE 10(9), e0137035 (2015)PubMedCentralCrossRefPubMed

go back to reference N.S. Lai, D.G. Wu, X.G. Fang, Y.C. Lin, S.S. Chen, Z.B. Li, S.S. Xu, Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma. Br. J. Cancer. 112(7), 1241–1246 (2015)PubMedCentralCrossRefPubMed N.S. Lai, D.G. Wu, X.G. Fang, Y.C. Lin, S.S. Chen, Z.B. Li, S.S. Xu, Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma. Br. J. Cancer. 112(7), 1241–1246 (2015)PubMedCentralCrossRefPubMed

go back to reference M. Xiang, Y. Zeng, R. Yang, H. Xu, Z. Chen, J. Zhong, H. Xie, Y. Xu, X. Zeng, U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem. Biophys. Res. Commun. 454(1), 210–214 (2014)CrossRefPubMed M. Xiang, Y. Zeng, R. Yang, H. Xu, Z. Chen, J. Zhong, H. Xie, Y. Xu, X. Zeng, U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem. Biophys. Res. Commun. 454(1), 210–214 (2014)CrossRefPubMed

go back to reference X. Zhang, S. Shao, H. Geng, Y. Yu, C. Wang, Z. Liu, C. Yu, X. Jiang, Y. Deng, L. Gao, J. Zhao, Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study. J. Clin. Endocrinol. Metab. 99(5), E766–E774 (2014)CrossRefPubMed X. Zhang, S. Shao, H. Geng, Y. Yu, C. Wang, Z. Liu, C. Yu, X. Jiang, Y. Deng, L. Gao, J. Zhao, Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study. J. Clin. Endocrinol. Metab. 99(5), E766–E774 (2014)CrossRefPubMed

go back to reference H. Wang, W. Peng, X. Ouyang, W. Li, Y. Dai, Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl. Res. 160(3), 198–206 (2012)CrossRefPubMed H. Wang, W. Peng, X. Ouyang, W. Li, Y. Dai, Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl. Res. 160(3), 198–206 (2012)CrossRefPubMed

go back to reference Y. Shao, H. Ren, C. Lv, X. Ma, C. Wu, Q. Wang, Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine 55(1), 130–138 (2017)CrossRefPubMed Y. Shao, H. Ren, C. Lv, X. Ma, C. Wu, Q. Wang, Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine 55(1), 130–138 (2017)CrossRefPubMed

go back to reference L. Jiang, J. Huang, Y. Chen, Y. Yang, R. Li, Y. Li, X. Chen, D. Yang, Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome. Endocrine 53(1), 280–290 (2016)CrossRefPubMed L. Jiang, J. Huang, Y. Chen, Y. Yang, R. Li, Y. Li, X. Chen, D. Yang, Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome. Endocrine 53(1), 280–290 (2016)CrossRefPubMed

go back to reference M. Pelloni, G. Coltrinari, D. Paoli, F. Pallotti, F. Lombardo, A. Lenzi, L. Gandini Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients. Endocrine (2016). [Epub ahead of print]. doi:10.1007/s12020-016-1150-z CrossRefPubMed M. Pelloni, G. Coltrinari, D. Paoli, F. Pallotti, F. Lombardo, A. Lenzi, L. Gandini Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients. Endocrine (2016). [Epub ahead of print]. doi:10.​1007/​s12020-016-1150-z CrossRefPubMed

go back to reference L. Shen, F. Huang, L. Ye, W. Zhu, X. Zhang, S. Wang, W. Wang, G. Ning, Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves’ ophthalmopathy. Endocrine 49(2), 445–456 (2015)CrossRefPubMed L. Shen, F. Huang, L. Ye, W. Zhu, X. Zhang, S. Wang, W. Wang, G. Ning, Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves’ ophthalmopathy. Endocrine 49(2), 445–456 (2015)CrossRefPubMed

go back to reference D.D. McManus, K. Tanriverdi, H. Lin, N. Esa, M. Kinno, D. Mandapati, S. Tam, O.N. Okike, P.T. Ellinor, J.F. Keaney Jr., J.K. Donahue, E.J. Benjamin, J.E. Freedman, Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study). Heart. Rhythm. 12(1), 3–10 (2015)CrossRefPubMed D.D. McManus, K. Tanriverdi, H. Lin, N. Esa, M. Kinno, D. Mandapati, S. Tam, O.N. Okike, P.T. Ellinor, J.F. Keaney Jr., J.K. Donahue, E.J. Benjamin, J.E. Freedman, Plasma microRNAs are associated with atrial fibrillation and change after catheter ablation (the miRhythm study). Heart. Rhythm. 12(1), 3–10 (2015)CrossRefPubMed

go back to reference Z. Liu, C. Zhou, Y. Liu, S. Wang, P. Ye, X. Miao, J. Xia, The expression levels of plasma micoRNAs in atrial fibrillation patients. PLoS ONE 7(9), e44906 (2012)PubMedCentralCrossRefPubMed Z. Liu, C. Zhou, Y. Liu, S. Wang, P. Ye, X. Miao, J. Xia, The expression levels of plasma micoRNAs in atrial fibrillation patients. PLoS ONE 7(9), e44906 (2012)PubMedCentralCrossRefPubMed

go back to reference Y. Goren, E. Meiri, C. Hogan, H. Mitchell, D. Lebanony, N. Salman, J.E. Schliamser, O. Amir, Relation of reduced expression of MiR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure. Am. J. Cardiol. 113(6), 976–981 (2014)CrossRefPubMed Y. Goren, E. Meiri, C. Hogan, H. Mitchell, D. Lebanony, N. Salman, J.E. Schliamser, O. Amir, Relation of reduced expression of MiR-150 in platelets to atrial fibrillation in patients with chronic systolic heart failure. Am. J. Cardiol. 113(6), 976–981 (2014)CrossRefPubMed

go back to reference T. Liu, S. Zhong, F. Rao, Y. Xue, Z. Qi, S. Wu, Catheter ablation restores decreased plasma miR-409-3p and miR-432 in atrial fibrillation patients. Europace. 18(1), 92–99 (2016)CrossRefPubMed T. Liu, S. Zhong, F. Rao, Y. Xue, Z. Qi, S. Wu, Catheter ablation restores decreased plasma miR-409-3p and miR-432 in atrial fibrillation patients. Europace. 18(1), 92–99 (2016)CrossRefPubMed

go back to reference S. Fazio, E.A. Palmieri, G. Lombardi, B. Biondi, Effects of thyroid hormone on the cardiovascular system. Recent. Prog. Horm. Res. 59, 31–50 (2004)CrossRefPubMed S. Fazio, E.A. Palmieri, G. Lombardi, B. Biondi, Effects of thyroid hormone on the cardiovascular system. Recent. Prog. Horm. Res. 59, 31–50 (2004)CrossRefPubMed

go back to reference W.H. Dillmann, Biochemical basis of thyroid hormone action in the heart. Am. J. Med. 88(6), 626–630 (1990)CrossRefPubMed W.H. Dillmann, Biochemical basis of thyroid hormone action in the heart. Am. J. Med. 88(6), 626–630 (1990)CrossRefPubMed

go back to reference M. Lagos-Quintana, R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, T. Tuschl, Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12(9), 735–739 (2002)CrossRefPubMed M. Lagos-Quintana, R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, T. Tuschl, Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12(9), 735–739 (2002)CrossRefPubMed

go back to reference P.K. Rao, Y. Toyama, H.R. Chiang, S. Gupta, M. Bauer, R. Medvid, F. Reinhardt, R. Liao, M. Krieger, R. Jaenisch, H.F. Lodish, R. Blelloch, Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ. Res. 105(6), 585–594 (2009)PubMedCentralCrossRefPubMed P.K. Rao, Y. Toyama, H.R. Chiang, S. Gupta, M. Bauer, R. Medvid, F. Reinhardt, R. Liao, M. Krieger, R. Jaenisch, H.F. Lodish, R. Blelloch, Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ. Res. 105(6), 585–594 (2009)PubMedCentralCrossRefPubMed

go back to reference D. Terentyev, A.E. Belevych, R. Terentyeva, M.M. Martin, G.E. Malana, D.E. Kuhn, M. Abdellatif, D.S. Feldman, T.S. Elton, S. Gyorke, miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ. Res. 104(4), 514–521 (2009)PubMedCentralCrossRefPubMed D. Terentyev, A.E. Belevych, R. Terentyeva, M.M. Martin, G.E. Malana, D.E. Kuhn, M. Abdellatif, D.S. Feldman, T.S. Elton, S. Gyorke, miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ. Res. 104(4), 514–521 (2009)PubMedCentralCrossRefPubMed

go back to reference Y. Lu, S. Hou, D. Huang, X. Luo, J. Zhang, J. Chen, W. Xu, Expression profile analysis of circulating microRNAs and their effects on ion channels in Chinese atrial fibrillation patients. Int. J. Clin. Exp. Med. 8(1), 845–853 (2015)PubMedCentralPubMed Y. Lu, S. Hou, D. Huang, X. Luo, J. Zhang, J. Chen, W. Xu, Expression profile analysis of circulating microRNAs and their effects on ion channels in Chinese atrial fibrillation patients. Int. J. Clin. Exp. Med. 8(1), 845–853 (2015)PubMedCentralPubMed

go back to reference B. Yang, H. Lin, J. Xiao, Y. Lu, X. Luo, B. Li, Y. Zhang, C. Xu, Y. Bai, H. Wang, G. Chen, Z. Wang, The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13(4), 486–491 (2007)CrossRefPubMed B. Yang, H. Lin, J. Xiao, Y. Lu, X. Luo, B. Li, Y. Zhang, C. Xu, Y. Bai, H. Wang, G. Chen, Z. Wang, The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 13(4), 486–491 (2007)CrossRefPubMed

go back to reference X. Jia, S. Zheng, X. Xie, Y. Zhang, W. Wang, Z. Wang, Y. Zhang, J. Wang, M. Gao, Y. Hou, MicroRNA-1 accelerates the shortening of atrial effective refractory period by regulating KCNE1 and KCNB2 expression: an atrial tachypacing rabbit model. PLoS ONE 8(12), e85639 (2013)PubMedCentralCrossRefPubMed X. Jia, S. Zheng, X. Xie, Y. Zhang, W. Wang, Z. Wang, Y. Zhang, J. Wang, M. Gao, Y. Hou, MicroRNA-1 accelerates the shortening of atrial effective refractory period by regulating KCNE1 and KCNB2 expression: an atrial tachypacing rabbit model. PLoS ONE 8(12), e85639 (2013)PubMedCentralCrossRefPubMed

go back to reference F. Stillitano, G. Lonardo, G. Giunti, M. Del Lungo, R. Coppini, V. Spinelli, L. Sartiani, C. Poggesi, A. Mugelli, E. Cerbai, Chronic atrial fibrillation alters the functional properties of If in the human atrium. J. Cardiovasc. Electrophysiol. 24(12), 1391–1400 (2013)CrossRefPubMed F. Stillitano, G. Lonardo, G. Giunti, M. Del Lungo, R. Coppini, V. Spinelli, L. Sartiani, C. Poggesi, A. Mugelli, E. Cerbai, Chronic atrial fibrillation alters the functional properties of If in the human atrium. J. Cardiovasc. Electrophysiol. 24(12), 1391–1400 (2013)CrossRefPubMed

go back to reference H.D. Yu, S. Xia, C.Q. Zha, S.B. Deng, J.L. Du, Q. She, Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction. J. Cardiovasc. Pharmacol. 65(6), 587–592 (2015)PubMedCentralCrossRefPubMed H.D. Yu, S. Xia, C.Q. Zha, S.B. Deng, J.L. Du, Q. She, Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction. J. Cardiovasc. Pharmacol. 65(6), 587–592 (2015)PubMedCentralCrossRefPubMed

go back to reference Y.D. Li, Y.F. Hong, Y. Yusufuaji, B.P. Tang, X.H. Zhou, G.J. Xu, J.X. Li, L. Sun, J.H. Zhang, Q. Xin, J. Xiong, Y.T. Ji, Y. Zhang, Altered expression of hyperpolarization-activated cyclic nucleotide-gated channels and microRNA-1 and -133 in patients with age-associated atrial fibrillation. Mol. Med. Rep. 12(3), 3243–3248 (2015)PubMedCentralCrossRefPubMed Y.D. Li, Y.F. Hong, Y. Yusufuaji, B.P. Tang, X.H. Zhou, G.J. Xu, J.X. Li, L. Sun, J.H. Zhang, Q. Xin, J. Xiong, Y.T. Ji, Y. Zhang, Altered expression of hyperpolarization-activated cyclic nucleotide-gated channels and microRNA-1 and -133 in patients with age-associated atrial fibrillation. Mol. Med. Rep. 12(3), 3243–3248 (2015)PubMedCentralCrossRefPubMed